Codes / ICD10CM / D57.44

D57.44 Sickle-cell thalassemia beta plus without crisis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Sickle-cell thalassemia beta plus without crisis

Summary

Sickle-cell thalassemia beta plus without crisis is a genetic blood disorder resulting from the co-inheritance of sickle cell disease and beta-plus thalassemia mutations. It causes red blood cells to become abnormal in shape and function, leading to complications such as anemia and organ damage. The absence of crisis indicates a stable phase without acute vaso-occlusive episodes.

Causes

Sickle-cell thalassemia arises from co-inheritance of mutations in the hemoglobin gene (HBB). One parent contributes a sickle cell mutation, while the other contributes a beta-plus thalassemia mutation. This combination alters hemoglobin structure, resulting in sickle-shaped red blood cells and reduced hemoglobin production.

Risk Factors

  • Family history of sickle-cell disease or thalassemia
  • Ethnic backgrounds with higher prevalence of these conditions (e.g., Mediterranean, Middle Eastern, Indian, or African descent)
  • Inheriting one sickle cell gene and one thalassemia gene increases the risk of passing the disorder to offspring

Symptoms

  • Fatigue and weakness due to anemia
  • Jaundice (yellowing of the skin or eyes)
  • Swelling in hands and feet (dactylitis)
  • Frequent infections
  • Delayed growth or puberty in children

Diagnosis

Diagnosis involves blood tests to identify sickle-shaped red blood cells and hemoglobin electrophoresis or high-performance liquid chromatography (HPLC) to confirm the specific hemoglobin variant. Genetic testing may be used to identify the underlying mutations.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. This may include folic acid supplementation, pain management, blood transfusions, and hydroxyurea to reduce sickle cell formation. Regular monitoring and vaccinations are also recommended.

Prognosis and Follow-Up

Prognosis varies based on the severity of the condition. Regular follow-up with a hematologist is essential to monitor for complications such as organ damage or anemia. Lifelong management is typically required.

Complications

Potential complications include chronic anemia, organ damage (e.g., spleen, liver, or kidneys), and increased risk of infections. Without proper management, these complications can worsen over time.

Lifestyle & Prevention

Maintaining a healthy diet, staying hydrated, and avoiding extreme temperatures can help reduce symptoms. Genetic counseling is recommended for individuals with a family history of the disorder.

When to Seek Professional Help

Seek medical attention if experiencing severe fatigue, jaundice, unexplained swelling, or signs of infection. Prompt care is important to manage acute symptoms and prevent complications.

Tips for Medical Coders

Document the absence of crisis and specify the beta-plus thalassemia component to accurately reflect the condition. Ensure clinical documentation supports the diagnosis and any associated treatments or complications.

Book a walkthrough

D57.44 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.